Ballicules.com

Lisdexamfetamine

VYVANSE

Pronunciation: lis-dex-am-FET-a-meen (VYE-vans)

Lisdexamfetamine ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Lisdexamfetamine ballicule
Lisdexamfetamine VYVANSE mascot mnemonic cartoon
Visual mnemonic: Lisdexamfetamine mascot
“Lis decks amp with feta to reVive Vance”

What it isCatecholamine-releasing dextroamphetamine prodrug; ADHD and binge-eating disorder.

Why this oneEnzymatic activation produces a slower rise and makes tampering less rewarding than with immediate-release amphetamine.

What limits itAppetite suppression, insomnia, tachycardia and blood-pressure rise can end treatment. Diversion and dependence still matter.

Lisdexamfetamine molecular structure (skeletal formula)
Molecular structure: Lisdexamfetamine

FDA-approved for

FDA label

BOXED WARNING High potential for abuse, misuse, and addiction; CNS stimulant misuse/abuse can result in overdose and death.
FDA dosingPopulationStartTargetMax
ADHDAdults & pediatric >=6 yr30 mg QAM30–70 mg/day (titrate 10–20 mg weekly)70 mg/day
Moderate to severe binge eating disorder (BED)Adults30 mg QAM (titrate 20 mg weekly)50–70 mg/day70 mg/day

Titration Adjust at approximately weekly intervals (ADHD: 10–20 mg; BED: 20 mg).

Renal Severe impairment (GFR 15–<30): max 50 mg/day; ESRD (GFR <15): max 30 mg/day; not dialyzable

Hepatic Undefined

Instructions

Available strengths

Contraindications

Cautions

Adverse reactions

Pregnancy Insufficient human data; amphetamine use is associated with premature delivery and low birth weight; monitor neonates for withdrawal.

Lactation Present in human milk; breastfeeding is not recommended during treatment.

Cost

Lisdexamfetamine (VYVANSE)
What pharmacies pay · NADAC 9/30/26
Strength#/mogeneric $/moCostPlus
10 mgcap4 q-wk$10.50not offered
20 mgcap4 q-wk$9.75not offered
30 mgcap4 q-wk$10.80not offered
40 mgcap4 q-wk$10.41not offered
50 mgcap4 q-wk$10.56not offered
60 mgcap4 q-wk$10.69not offered
70 mgcap4 q-wk$10.70not offered
10 mgchew tab4 q-wk$14.95not offered
20 mgchew tab4 q-wk$17.35not offered
30 mgchew tab4 q-wk$13.17not offered
40 mgchew tab4 q-wk$15.92not offered
50 mgchew tab4 q-wk$14.59not offered
60 mgchew tab4 q-wk$14.58not offered

Generic entry2023

⚠ BOXED WARNING

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger3 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityCardiovascular stimulation, appetite suppression, insomnia, misuse and stimulant-induced psychosis.

Serotonin and MAOI

Provisional washout figures

SRI significance0 / 4
MAO-A inhibition0 / 4
Serotonin release1 / 4

Elevating mechanismNone identified

Non-elevating actionNone recorded

Exposure dependenceNo serotonin-elevating mechanism identified

Evidence confidenceModerate

InterpretationNo clinically meaningful serotonin-elevating mechanism identified in this first-pass Gillman-based review.

Active metabolites

Open Lisdexamfetamine in the interactive console ↗